Tracey Pirali

5.2k total citations · 4 hit papers
67 papers, 4.2k citations indexed

About

Tracey Pirali is a scholar working on Organic Chemistry, Molecular Biology and Sensory Systems. According to data from OpenAlex, Tracey Pirali has authored 67 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Organic Chemistry, 32 papers in Molecular Biology and 8 papers in Sensory Systems. Recurrent topics in Tracey Pirali's work include Click Chemistry and Applications (17 papers), Multicomponent Synthesis of Heterocycles (16 papers) and Synthesis and biological activity (12 papers). Tracey Pirali is often cited by papers focused on Click Chemistry and Applications (17 papers), Multicomponent Synthesis of Heterocycles (16 papers) and Synthesis and biological activity (12 papers). Tracey Pirali collaborates with scholars based in Italy, United Kingdom and Spain. Tracey Pirali's co-authors include Armando A. Genazzani, Gian Cesare Tron, Giovanni Sorba, M. Teresa Serafini, Sarah Cargnin, Pier Luigi Canonico, Richard Billington, Francesca Pagliai, Rita Maria Concetta Di Martino and Brad D. Maxwell and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Reviews Drug Discovery and Chemical Communications.

In The Last Decade

Tracey Pirali

65 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Click chemistry reactions in medicinal chemistry: Applications of the 1,3‐dipolar cycloaddition between azides and alkynes

2007 861 citations Gian Cesare Tron, Tracey Pirali et al. Medicinal Research Reviews profile →
Applications of Deuterium in Medicinal Chemistry

2019 633 citations Tracey Pirali, M. Teresa Serafini et al. Journal of Medicinal Chemistry profile →
Medicinal Chemistry of Combretastatin A4: Present and Future Directions

2006 568 citations Gian Cesare Tron, Tracey Pirali et al. Journal of Medicinal Chemistry profile →
Deuterium in drug discovery: progress, opportunities and challenges

2023 299 citations Rita Maria Concetta Di Martino, Brad D. Maxwell et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tracey Pirali Italy	27	2.8k	1.6k	753	432	243	67	4.2k
Tomohiko Ohwada Japan	40	2.9k 1.0×	1.7k 1.0×	155 0.2×	464 1.1×	127 0.5×	198	5.0k
Mark T. Bilodeau United States	30	3.4k 1.2×	2.0k 1.3×	102 0.1×	458 1.1×	222 0.9×	67	4.6k
Christopher A. Ramsden United Kingdom	28	1.9k 0.7×	697 0.4×	228 0.3×	322 0.7×	113 0.5×	160	3.6k
Matteo Zanda Italy	36	2.7k 1.0×	1.8k 1.1×	1.6k 2.2×	437 1.0×	368 1.5×	209	4.6k
William K. Hagmann United States	25	3.2k 1.1×	1.4k 0.8×	2.5k 3.3×	864 2.0×	262 1.1×	78	5.4k
Yasumaru Hatanaka Japan	26	1.5k 0.5×	1.6k 1.0×	271 0.4×	58 0.1×	148 0.6×	161	2.8k
Nicole A. Kratochwil Switzerland	24	607 0.2×	1.3k 0.8×	272 0.4×	155 0.4×	78 0.3×	50	2.4k
Takayuki Doi Japan	39	3.4k 1.2×	1.9k 1.2×	109 0.1×	311 0.7×	894 3.7×	262	5.3k
Romeo Romagnoli Italy	47	4.6k 1.6×	3.0k 1.9×	106 0.1×	232 0.5×	527 2.2×	242	7.0k

Countries citing papers authored by Tracey Pirali

Since Specialization

Citations

This map shows the geographic impact of Tracey Pirali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracey Pirali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracey Pirali more than expected).

Fields of papers citing papers by Tracey Pirali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracey Pirali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracey Pirali. The network helps show where Tracey Pirali may publish in the future.

Co-authorship network of co-authors of Tracey Pirali

This figure shows the co-authorship network connecting the top 25 collaborators of Tracey Pirali. A scholar is included among the top collaborators of Tracey Pirali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tracey Pirali. Tracey Pirali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martino, Rita Maria Concetta Di, et al.. (2025). Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery. Journal of Medicinal Chemistry. 68(22). 23676–23689. 1 indexed citations

Tommasi, Nunziatina De, Rita Maria Concetta Di Martino, Beatrice Riva, et al.. (2025). Calcium signaling dysregulation in rheumatoid arthritis: a comparative perspective with osteoarthritis. Autoimmunity Reviews. 24(12). 103923–103923.

Serafini, M. Teresa, Silvio Aprile, Emanuela Pessolano, et al.. (2024). The multicomponent Passerini reaction as a means of accessing diversity in structure, activity and properties: Soft and hard vanilloid/cannabinoid modulators. European Journal of Medicinal Chemistry. 279. 116845–116845. 2 indexed citations

Angeli, Andrea, Laura Micheli, Fabrizio Carta, et al.. (2023). First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy. Journal of Medicinal Chemistry. 66(2). 1616–1633. 14 indexed citations

Martino, Rita Maria Concetta Di, Brad D. Maxwell, & Tracey Pirali. (2023). Deuterium in drug discovery: progress, opportunities and challenges. Nature Reviews Drug Discovery. 22(7). 562–584. 299 indexed citations breakdown →

Pessolano, Emanuela, Beatrice Riva, Nausicaa Clemente, et al.. (2022). CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy. Blood Advances. 6(15). 4471–4484. 10 indexed citations

Riva, Beatrice, Emanuela Pessolano, Ana Töpf, et al.. (2022). STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39. Cell Calcium. 105. 102605–102605. 10 indexed citations

Serafini, M. Teresa, et al.. (2021). The 115 Years Old Multicomponent Bargellini Reaction: Perspectives and New Applications. Molecules. 26(3). 558–558. 13 indexed citations

Fallarini, Silvia, Silvio Aprile, Eleonora Panfili, et al.. (2021). The [1,2,4]Triazolo[4,3‐a]pyridine as a New Player in the Field of IDO1 Catalytic Holo‐Inhibitors. ChemMedChem. 16(22). 3439–3450. 5 indexed citations

10.

Adamo, Annalisa, et al.. (2021). Moonlighting Proteins Are Important Players in Cancer Immunology. Frontiers in Immunology. 11. 613069–613069. 24 indexed citations

11.

González‐Rodríguez, Sara, Isabel Devesa, Pierluigi Valente, et al.. (2021). A capsaicinoid-based soft drug, AG1529, for attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability. Scientific Reports. 11(1). 246–246. 24 indexed citations

12.

Riva, Beatrice, Simone Reano, Nausicaa Clemente, et al.. (2019). A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy. Disease Models & Mechanisms. 13(2). 18 indexed citations

13.

Aprile, Silvio, M. Teresa Serafini, & Tracey Pirali. (2019). Soft drugs for dermatological applications: recent trends. Drug Discovery Today. 24(12). 2234–2246. 12 indexed citations

14.

Pirali, Tracey, Elisa Ciraolo, Silvio Aprile, et al.. (2017). Identification of a Potent Phosphoinositide 3‐Kinase Pan Inhibitor Displaying a Strategic Carboxylic Acid Group and Development of Its Prodrugs. ChemMedChem. 12(18). 1542–1554. 19 indexed citations

15.

Zaninetti, Roberta, Silvio Aprile, Alberto Massarotti, et al.. (2013). A Concise Synthesis of Pyrazole Analogues of Combretastatin A1 as Potent Anti‐Tubulin Agents. ChemMedChem. 8(4). 633–643. 30 indexed citations

16.

Braccini, Laura, Elisa Ciraolo, Miriam Martini, et al.. (2012). PI3K keeps the balance between metabolism and cancer. Advances in Biological Regulation. 52(3). 389–405. 38 indexed citations

17.

Lu, Xiaoyun, Alberto Massarotti, Antonio Caldarelli, et al.. (2011). Groebke multicomponent reaction and subsequent nucleophilic aromatic substitution for a convenient synthesis of 3,8-diaminoimidazo[1,2-a]pyrazines as potential kinase inhibitors. Organic & Biomolecular Chemistry. 9(11). 4144–4144. 14 indexed citations

18.

Massarotti, Alberto, Mariateresa Giustiniano, Tracey Pirali, et al.. (2010). Replacement of the double bond of antitubulin chalcones with triazoles and tetrazoles: Synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters. 21(2). 764–768. 47 indexed citations

19.

Tron, Gian Cesare, Tracey Pirali, Richard Billington, et al.. (2007). Click chemistry reactions in medicinal chemistry: Applications of the 1,3‐dipolar cycloaddition between azides and alkynes. Medicinal Research Reviews. 28(2). 278–308. 861 indexed citations breakdown →

20.

Giovenzana, Giovanni B., et al.. (2006). A Mimicry of Primary Amines by Bis‐Secondary Diamines as Components in the Ugi Four‐Component Reaction. Angewandte Chemie International Edition. 45(7). 1099–1102. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact